Frontlight ResearchEarly access
Not yet recruitingNo phase
Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.
Key facts
- Who runs it
- Sanofi
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- NCT06694025
- U1111-1251-6083
- Status
- Not yet recruiting
- People taking part
- 670 people, planned
- Started
- 1 Oct 2026
- Expected to end
- 31 Jan 2028
- Type of study
- Observational
- Treatments tested
- Efluelda Tetra Pre-filled syringe
- Record updated
- 15 December 2025
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Adults aged 65 years or older on the day of enrollment
- The informed consent form has been signed and dated
- Receipt of 1 dose of Efluelda Tetra on the day of enrollment according to the approved local product label
Who cannot take part
- Previous history of enrollment in this study
- Participation at the time of study enrollment (or in the 4 weeks preceding the enrollment) or planned participation during the present study period in a clinical study investigating a vaccine, drug, medical device or medical procedure
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To investigate the incidence of adverse events (AEs) and adverse drug reactions (ADRs) occurred following administration of Efluelda Tetra in adults aged 65 years or older under routine clinical practice, as per approved indications.
Read full original descriptionShow less
The study duration of each participation will be approximately 28 to 35 days. In the event that Visit 2 is not made, the study duration would be extended to 36 to 42 days.
The group in the trial
- Efluelda group
A single dose of 0.7 mL is administered as approved by MFDS.
Treatment: Efluelda Tetra Pre-filled syringe
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe, a High-dose Quadrivalent Influenza Vaccine Administered to Adults 65 Years or Older in the Republic of Korea.
- Record updated
- 15 December 2025